⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5888235 | 0.71 | — | — | |
| SCHEMBL580953 | 0.67 | — | — | |
| SCHEMBL6427950 | 0.67 | — | — | |
| SCHEMBL8508693 | 0.67 | — | — | |
| SCHEMBL17157487 | 0.67 | — | — | |
| SCHEMBL3628674 | 0.67 | — | — | |
| SCHEMBL1431147 | 0.67 | — | — | |
| SCHEMBL27639 | 0.62 | — | — | |
| SCHEMBL8506228 | 0.62 | — | — | |
| SCHEMBL2146911 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111808118-A | Phosphorescent material, manufacturing method thereof and OLED device | 上海和辉光电有限公司 | 2020-10-23 | — | — | CN | claimed |
| EP-3820859-B1 | INHIBITORS OF HISTONE DEACETYLASE | ALKERMES INC (US) | 2024-03-20 | — | — | EP | disclosed |
| US-20210276978-A1 | INHIBITORS OF HISTONE DEACETYLASE | ALKERMES, INC. | 2021-09-09 | — | — | US | disclosed |
| EP-3820859-A1 | INHIBITORS OF HISTONE DEACETYLASE | Alkermes, Inc. (US) | 2021-05-19 | — | — | EP | disclosed |
| CN-112424184-A | Bicyclic inhibitors of histone deacetylase | 奥克梅斯公司 | 2021-02-26 | — | — | CN | disclosed |
| CN-111808118-A | Phosphorescent material, manufacturing method thereof and OLED device | 上海和辉光电有限公司 | 2020-10-23 | — | — | CN | disclosed |
| US-10550140-B2 | Ether compounds for treatment of complement mediated disorders | ACHILLION PHARMACEUTICALS, INC. (US) | 2020-02-04 | — | — | US | disclosed |
| US-10385097-B2 | Ether compounds for treatment of medical disorders | ACHILLION PHARMACEUTICALS, INC. (US) | 2019-08-20 | — | — | US | disclosed |
| US-20190048033-A1 | ETHER COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS | ACHILLION PHARMACEUTICALS, INC. (US) | 2019-02-14 | — | — | US | disclosed |
| US-10106563-B2 | Ether compounds for treatment of complement mediated disorders | Achillion Pharmaecuticals, Inc. (US) | 2018-10-23 | — | — | US | disclosed |
| US-7652051-B2 | Heterocyclic compounds and methods of use | TARGEGEN, INC. (US) | 2010-01-26 | — | — | US | disclosed |
| US-20090306121-A1 | AZA-BETA-CARBOLINES AND METHODS OF USING SAME | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-12-10 | — | — | US | disclosed |
| WO-2009143445-A1 | AZA-BETA-CARBOLINES AND METHODS OF USING SAME | THE UWM RESEARCH FOUNDATION, INC (US) | 2009-11-26 | — | — | WO | disclosed |
| EP-1799656-A4 | HETEROCYCLIC COMPOUNDS AND METHODS OF USE | TARGEGEN INC (US) | 2009-09-02 | — | — | EP | disclosed |
| EP-1799656-A1 | HETEROCYCLIC COMPOUNDS AND METHODS OF USE | Targegen, Inc. (US) | 2007-06-27 | — | — | EP | disclosed |
| US-20060079526-A1 | Heterocyclic compounds and methods of use | TARGEGEN, INC. (US) | 2006-04-13 | — | — | US | disclosed |
| WO-2006024034-A1 | HETEROCYCLIC COMPOUNDS AND METHODS OF USE | TARGEGEN, INC. (US) | 2006-03-02 | — | — | WO | disclosed |
| EP-0148826-A1 | FUNGICIDAL, HERBICIDAL AND PLANT GROWTH REGULATING PYRIDYL-CONTAINING ETHERS | CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) | 1985-07-24 | — | — | EP | disclosed |
| WO-1985000289-A1 | FUNGICIDAL, HERBICIDAL AND PLANT GROWTH REGULATING PYRIDYL-CONTAINING ETHERS | CHEVRON RESEARCH COMPANY (US) | 1985-01-31 | — | — | WO | disclosed |
| EP-0037591-A1 | Phenoxy-pyrimidinyl alkanols, process for their preparation and their use as fungicides | BAYER AG (DE) | 1981-10-14 | — | — | EP | disclosed |